Johnson & Johnson vs. Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
JNJ
Johnson & Johnson
$276.22 +1.43%
VS KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares
$96.12 +3.03%
Johnson & Johnson and Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | KNSA | |
|---|---|---|
| Market Cap | $664.95 billion | $7.33 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | KNSA | |
|---|---|---|
| Dividend Yield | 1.94% | — |
JNJ and KNSA split the dividend factors evenly.
Risk & Sentiment
| JNJ | KNSA | |
|---|---|---|
| Short Interest | 0.67% | 0.02% |
KNSA leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, KNSA overview, KNSA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.